Stockholm, Sweden Monday, June 30, 2025, 10:00 Hrs [IST] ...

FDA approves Gamifant® (emapalumab-lzsg) as first-ever treatment for adults and children with Macrophage Activation ...

Swedish Orphan Biovitrum, the Nordic biotech also known as Sobi, on Friday announced that the US Food and Drug Administration ...

Swedish Orphan Biovitrum, the Nordic biotech also known as Sobi, on Friday announced that the U.S. Food and Drug ...

The European Commission has approved the first biosimilar version of Actemra/RoActemra, Roche’s $3 billion blockbuster, from German drugmaker Fresenius Kabi.

Biogen says it is the first drugmaker in the US to get FDA approval for a biosimilar of Roche’s $3 billion blockbuster product Actemra. The intravenous biosimilar of IL-6 inhibitor Actemra ...

polyarticular juvenile idiopathic arthritis; It may cause certain side effects, some of which can be serious. But in most cases, Rinvoq’s side effects tend to be mild.

Find rheumatology news articles, videos, blogs, books, Continuing Medical Education (CME), meeting coverage, and journal articles.